Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion

Int J Gynaecol Obstet. 2008 Jul;102(1):55-9. doi: 10.1016/j.ijgo.2008.02.006. Epub 2008 Apr 16.

Abstract

Objective: To further the understanding of the mechanism behind myoma necrosis and uterus survival after uterine artery occlusion.

Method: Myomal and myometrial gene transcription and protein expression of tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1) were investigated in 30 uteri.

Results: Compared with myometrial expression, myomal expression was less for uPA mRNA (1.34%+/-2.18% vs 2.84%+/-2.97%; P<0.05) and greater for PAI-1 mRNA (2.67%+/-1.82% vs 1.27%+/-1.99%; P<0.05), but the difference in tPA mRNA expression was not significant. Accordingly, compared with myometrial expression, myomal expression was less for the uPA protein (P<0.05) and greater for the PAI-1 protein (P<0.05), but the difference in tPA protein was not significant.

Conclusion: The PA/PAI system was found to be expressed differently in myomas and the myometrium, which may play a role in uterus survival and myoma necrosis after uterine artery occlusion.

MeSH terms

  • Adult
  • Embolization, Therapeutic
  • Female
  • Humans
  • Leiomyoma / metabolism*
  • Leiomyoma / therapy*
  • Middle Aged
  • Myometrium / metabolism
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Tissue Plasminogen Activator / metabolism*
  • Urokinase-Type Plasminogen Activator / metabolism*
  • Uterine Neoplasms / metabolism*
  • Uterine Neoplasms / therapy*
  • Uterus / blood supply

Substances

  • Plasminogen Activator Inhibitor 1
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator